Hedgehog Pathway Inhibitors against Tumor Microenvironment

Targeting the hedgehog (HH) pathway to treat aggressive cancers of the brain, breast, pancreas, and prostate has been ongoing for decades. Gli gene amplifications have been long discovered within malignant glioma patients, and since then, inhibitors against HH pathway-associated molecules have succe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gampala, Silpa, Yang, Jer-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619966/
https://www.ncbi.nlm.nih.gov/pubmed/34831357
http://dx.doi.org/10.3390/cells10113135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619966/
https://www.ncbi.nlm.nih.gov/pubmed/34831357
http://dx.doi.org/10.3390/cells10113135

Ejemplares similares